North America Advanced Wound Care Management Market Forecast 2021-2028

Inkwood Research
166 Pages - INKWOOD10154
$1,250.00

KEY FINDINGS
The North America advanced wound care management market is anticipated to register a CAGR of 11.43% during the forecasting years. The regional market’s growth is driven by factors such as the easy accessibility to wound care products, the availability of advanced healthcare facilities with trained medical professionals, the surging cases of road and sports accidents, and the increasing incidence of chronic conditions like obesity as well as diabetes.
MARKET INSIGHTS
The North America advanced wound care management market growth assessment entails the analysis of Canada and the United States. The annual cost of wound care in Canada is $4.5 billion. Despite the substantial expenditure, limited investment has been observed in the country, especially for the development of a wound care strategy for advanced healthcare management. Moreover, as per Wounds Canada, the nation lacks standardization in terms of selecting an appropriate healthcare provider for wound identification and management.
Leading players across the Canadian healthcare industry are innovating a strategy to convince healthcare decision-makers about the need for advanced practices in wound care. This measure would provide added clarity to the fact that compromised wounds are a co-condition of several common diseases, including diabetes, cancer, and cardiovascular disease. Moreover, 1.7% of patients admitted to hospitals following traumatic injuries or post-surgical procedures are likely to develop surgical site infections or pressure ulcers, thereby bolstering the demand for advanced wound care. Thus, these factors are projected to drive the North America advanced wound care management market over the forecasting period.
COMPETITIVE INSIGHTS
Prominent companies operating in the market are 3M Company, Adynxx Inc, Johnson & Johnson, Integra Lifesciences Holdings Corporation, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

'

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. SURGING AGING POPULATION
3.1.2. INCIDENCE OF CHRONIC DISEASES
3.1.3. ADVANCEMENT IN TECHNOLOGY
3.2. KEY RESTRAINTS
3.2.1. HIGH COST OF ADVANCED WOUND CARE PRODUCTS
3.2.2. LACK OF TRAINED PROFESSIONALS
4. KEY ANALYTICS
4.1. IMPACT OF COVID-19 ON ADVANCED WOUND CARE MANAGEMENT MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER’S FIVE FORCES ANALYSIS
4.3.1. BUYER’S POWER
4.3.2. SUPPLIER’S POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRY
4.3.5. INDUSTRY RIVALRY
4.4. OPPORTUNITY MATRIX
4.5. VENDOR LANDSCAPE
5. MARKET BY PRODUCT
5.1. THERAPY DEVICES
5.2. EXUDATE MANAGEMENT
5.3. INFECTION MANAGEMENT
5.4. ACTIVE WOUND CARE
6. MARKET BY APPLICATION
6.1. CHRONIC WOUNDS
6.2. ACUTE WOUNDS
7. MARKET BY END-USER
7.1. HOSPITALS
7.2. COMMUNITY HEALTH SERVICE CENTERS
8. GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1. MARKET SIZE & ESTIMATES
8.1.2. KEY GROWTH ENABLERS
8.1.3. KEY CHALLENGES
8.1.4. KEY PLAYERS
8.1.5. COUNTRY ANALYSIS
8.1.5.1. UNITED STATES
8.1.5.2. CANADA
9. COMPETITIVE LANDSCAPE
9.1. KEY STRATEGIC DEVELOPMENTS
9.1.1. MERGERS & ACQUISITIONS
9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
9.1.3. PARTNERSHIPS & AGREEMENTS
9.1.4. BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
9.2. COMPANY PROFILES
9.2.1. 3M COMPANY
9.2.2. B BRAUN MELSUNGEN AG
9.2.3. COLOPLAST
9.2.4. CONVATEC GROUP PLC
9.2.5. ESSITY AB
9.2.6. HARTMANN GROUP
9.2.7. HOLLISTER INCORPORATED
9.2.8. INTEGRA LIFESCIENCES HOLDINGS CORPORATION
9.2.9. JOHNSON & JOHNSON (ETHICON INC)
9.2.10. MEDTRONIC PLC
9.2.11. MEDLINE INDUSTRIES INC
9.2.12. MOLNLYCKE HEALTH CARE AB
9.2.13. ORGANOGENESIS HOLDINGS INC
9.2.14. SMITH & NEPHEW PLC

1. 3M COMPANY
2. B BRAUN MELSUNGEN AG
3. COLOPLAST
4. CONVATEC GROUP PLC
5. ESSITY AB
6. HARTMANN GROUP
7. HOLLISTER INCORPORATED
8. INTEGRA LIFESCIENCES HOLDINGS CORPORATION
9. JOHNSON & JOHNSON (ETHICON INC)
10. MEDTRONIC PLC
11. MEDLINE INDUSTRIES INC
12. MOLNLYCKE HEALTH CARE AB
13. ORGANOGENESIS HOLDINGS INC
14. SMITH & NEPHEW PLC

$1,250.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838